MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Apomorphine subcutaneous infusion reduces dopaminergic dosage whilst maintaining motor benefits in Parkinson’s disease: A prospective analysis of Thai Apomorphine Registry

    O. Phokaewvarangkul, K. Boonpang, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To evaluate a reduction of LED in PD patients who achieve satisfactory motor control with long-term continuous subcutaneous apomorphine infusion (CSAI) Background: Apomorphine is…
  • MDS Virtual Congress 2020

    12-month therapeutic evaluation of l-dopa carbidopa ascorbic acid solution (LCAS) in a cohort of Advanced Parkinson’s disease in a North-Indian tertiary care hospital

    K. Shukla, N. Sawal (Chandigarh, India)

    Objective: To prescribe LCAS to Parkinson’s disease(PD) patients whose symptoms were not adequately controlled on tablet l-dopa and compare the UPDRS-(I,II,III,IV) ON & OFF on…
  • MDS Virtual Congress 2020

    Evaluation of Advanced Parkinson’s Patients Using Levodopa Carbidopa Instestinal Gel: Results of the Aegean Region of Turkey

    O. Yilmaz Kusbeci, A. Acarer, B. Donmez Colakoglu, I. Inci, R. Cakmur, A. Akyol, Z. Colakoglu (Izmir, Turkey)

    Objective: The aim of the present study was to evaluate the outcome of LCIG treatment in advanced PD in Aegean Region of Turkey. Background: Levodopa/carbidopa…
  • MDS Virtual Congress 2020

    Treatment of Neurogenic Orthostatic Hypotension (nOH) in Multiple System Atrophy (MSA) with a wearable Pneumatic Compression Garment utilising Soft Robotics

    N. Sawal, H. Singh, A. Beri (Chandigarh, India)

    Objective: To use a novel Pneumatic Garment device for treatment of nOH in MSA. Background: nOH is present in 66-90% of patients with MSA and…
  • MDS Virtual Congress 2020

    Photophobia and Progressive Supranuclear Palsy

    K. Hay, D. Mohanty, Y. Lin, H. Kang, J. Sellers-Gibson, D. Claassen (Nashville, TN, USA)

    Objective: To characterize the prevalence, symptoms, and severity of light sensitivity in Progressive Supranuclear palsy (PSP)). Background: Photophobia is a commonly encountered clinical symptom in…
  • MDS Virtual Congress 2020

    Use of Figurative Language in Describing OFF Periods in Parkinson’s Disease

    B. Edison, S. Mantri, M. Daeschler, C. Kopil, C. Marras, S. Kahl, L. Chahine (Pittsburgh, PA, USA)

    Objective: To explore the use of figurative language by individuals with Parkinson’s disease (PD) describing their experience during OFF periods. Background: OFF periods are characterized…
  • MDS Virtual Congress 2020

    Socio-economic determinants of diagnostic latency in Parkinson’s disease patients

    P. Surathi, E. Feinstein (Newark, NJ, USA)

    Objective: Early diagnosis is important in optimal management of patients with Parkinson’s disease (PD). There are several factors which can contribute to delay in diagnosis,…
  • MDS Virtual Congress 2020

    Diverse Phenotypic Variations Among Siblings with NBIA: A Case Report and Review of Literature

    N. Merghany, A. Al Hasany (Cairo, Egypt)

    Objective: The purpose of this case report and  literature review  is to increase the awareness of  practicing clinicians regarding  the mosaic clinical pattern this disease…
  • MDS Virtual Congress 2020

    Functional Movement Disorder in Young Athletes: A Retrospective Case Series

    A. Lingaiah, D. Mohanty, M. Jablonski, K. LaFaver (Louisville, KY, USA)

    Objective: To present six young athletes with functional movement disorder (FMD) engaged in competitive high school or college sports. Background: FMD is defined by involuntary…
  • MDS Virtual Congress 2020

    Higher exercise self-efficacy is a predictor of clinically meaningful walking activity change in people with Parkinson disease

    C. Colon-Semenza, J. Zajac, T. DeAngelis, T. Ellis (Boston, MA, USA)

    Objective: To determine which factors at baseline predict responsiveness to a 12 month physical activity intervention in people with Parkinson’s disease (PD). Background: Previous studies…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley